Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
about
The role of antiplatelet therapy in the management of acute coronary syndromesRole of abciximab in the treatment of coronary artery diseaseAre patients with non-ST elevation myocardial infarction undertreated?Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome.Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDevelopment of glycoprotein IIb-IIIa antagonists: translation of pharmacodynamic effects into clinical benefit.Facilitated percutaneous coronary intervention in acute myocardial infarction: attractive concept but difficult to prove!ST segment elevation differs depending on the method of measurement.Myocardial infarction: contemporary management strategies.Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition.Balancing potency of platelet inhibition with bleeding risk in the early treatment of acute coronary syndrome.Acute coronary syndromes: Diagnosis and management, part II.Systematic review of fibrinolytic-facilitated percutaneous coronary intervention: potential benefits and future challenges.Thrombolytics and myocardial infarction.Anti-platelet therapy: glycoprotein IIb-IIIa antagonistsMicrovascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study.Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.Creating synergy in our health system: The challenges of primary angioplastyReperfusion therapy in acute ischemic stroke: dawn of a new era?CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018.
P2860
Q28176548-64CE9A34-FA75-46DD-A1B5-801D9C9F36E5Q28200177-F9550315-E65C-4DA5-BE2D-C7591239BE80Q28219991-CA8D3373-2FB4-4BD2-A5D1-E8BE4348324DQ35139249-0CAF2B8F-FF04-4149-9834-13063D72AFBCQ35752619-AFC800D2-81F2-494B-B709-06142C023A14Q35925710-BAC9761E-77CE-4F98-BFEB-4CC01E55C8FAQ35945662-123EF136-F041-4581-A713-9333A1E90AF4Q36419098-A86099AD-5668-4F5C-AB7B-113A7030D201Q36863859-DFA8EA5D-D77A-4063-A57A-381CAF817063Q37226395-4C8EAE5F-8A2C-495D-BC67-35E8FFC67C2AQ37311337-30779FDD-2A3D-4B50-A0DA-1B7DD40293F7Q37406719-78030B78-933A-4CDB-AD46-9EF6143490A9Q37412974-44392B43-6C8C-46E9-8729-7335EC0CF0B4Q37808766-779801F5-EE39-4D20-A931-B2749F984D46Q37929839-3145D37F-4DAC-4BEA-A46F-6D198EE4E0CFQ38605332-A0107D2B-3C67-47BB-87C7-4429ABC0E001Q38724104-B4F569BE-C07C-43E6-A4A5-F60987EDB511Q42633796-6180CBC6-4979-486A-88EF-CBB68E14729CQ47861990-D29D3FFB-4EBC-42CA-95E0-A07085E552EEQ55154820-6775C368-83C9-488E-BBCC-8A56E3EC6AD5
P2860
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Mortality at 1 year with combi ...... ion: GUSTO V randomized trial.
@en
Mortality at 1 year with combi ...... ion: GUSTO V randomized trial.
@nl
type
label
Mortality at 1 year with combi ...... ion: GUSTO V randomized trial.
@en
Mortality at 1 year with combi ...... ion: GUSTO V randomized trial.
@nl
prefLabel
Mortality at 1 year with combi ...... ion: GUSTO V randomized trial.
@en
Mortality at 1 year with combi ...... ion: GUSTO V randomized trial.
@nl
P2093
P50
P356
P1476
Mortality at 1 year with combi ...... ion: GUSTO V randomized trial.
@en
P2093
Alec Vahanian
Diego Ardissino
Global Use of Strategies To Open Coronary Arteries Investigators (GUSTO)
James T Willerson
Joan E Booth
Kathy Wolski
Michael Waller
P Gabriel Steg
Stefano Savonitto
P304
P356
10.1001/JAMA.288.17.2130
P407
P50
P577
2002-11-01T00:00:00Z